Normelena Defatima Rios, MD
Obstetrics/Gynecology · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rios’s office at (510) 307-1500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A108277 · Current
Licensed to practise in California · since 2009 · expires 2027-01-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$0 in 2024
Medicaid paid $0 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TOBACCO NON-USER | 13 | $0 |
| 2024 | 13 | 1 | 12 | $0 |
Drugs they prescribed that Part D paid
$57,405
Pharmacies billed $57,405 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
312 generic and 68 brand-name prescriptions · $57,405 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estring | 34 | $20,748 | $610 |
| Orilissa | 13 | $15,683 | $1,206 |
| Yuvafem | 41 | $4,722 | $115 |
| Estradiol | 80 | $3,019 | $38 |
| Progesterone | 38 | $1,629 | $43 |
See all 7 drugs
| Estring | 34 | $20,748 | $610 |
| Orilissa | 13 | $15,683 | $1,206 |
| Yuvafem | 41 | $4,722 | $115 |
| Estradiol | 80 | $3,019 | $38 |
| Progesterone | 38 | $1,629 | $43 |
| Gabapentin | 12 | $356 | $30 |
| Clobetasol Propionate | 18 | $256 | $14 |
Year by year
| 2024 | 380 | 129 | None | 18% | $57,405 |
| 2023 | 357 | 119 | None | 22% | $53,925 |
| 2022 | 355 | 115 | None | 20% | $43,478 |
| 2021 | 349 | 114 | None | 23% | $48,510 |
| 2020 | 290 | 95 | None | 21% | $33,363 |
| 2019 | 245 | 88 | None | 23% | $32,153 |
| 2018 | 199 | 83 | None | 24% | $26,221 |
| 2017 | 153 | 58 | None | 33% | $23,520 |
| 2016 | 163 | 60 | 0% (0) | 33% | $21,270 |
| 2015 | 114 | 45 | None | 33% | $11,829 |
| 2014 | 101 | 43 | None | 34% | $7,743 |
| 2013 | 90 | 42 | None | 36% | $5,939 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Estring | 49 | $29,677 | $606 |
| Yuvafem | 28 | $3,808 | $136 |
| Estradiol | 85 | $3,122 | $37 |
| Progesterone | 21 | $1,336 | $64 |
| Clobetasol Propionate | 25 | $399 | $16 |
| Acyclovir | 22 | $392 | $18 |
2022: 6 drugs
| Estring | 42 | $23,779 | $566 |
| Yuvafem | 30 | $5,012 | $167 |
| Estradiol | 89 | $3,227 | $36 |
| Progesterone | 20 | $1,394 | $70 |
| Clobetasol Propionate | 21 | $539 | $26 |
| Acyclovir | 22 | $534 | $24 |
2021: 6 drugs
| Estring | 51 | $28,065 | $550 |
| Estradiol | 85 | $4,033 | $47 |
| Yuvafem | 11 | $1,889 | $172 |
| Progesterone | 22 | $1,470 | $67 |
| Clobetasol Propionate | 24 | $869 | $36 |
| Hydrocortisone | 14 | $166 | $12 |
2020: 8 drugs
| Estring | 40 | $21,340 | $534 |
| Estradiol | 73 | $3,722 | $51 |
| Climara | 12 | $1,463 | $122 |
| Progesterone | 21 | $1,419 | $68 |
| Clobetasol Propionate | 24 | $721 | $30 |
| Gabapentin | 17 | $419 | $25 |
| Hydrocortisone | 15 | $207 | $14 |
| Triamcinolone Acetonide | 11 | $90 | $8 |
2019: 4 drugs
| Estring | 34 | $17,292 | $509 |
| Estradiol | 61 | $2,801 | $46 |
| Progesterone | 13 | $1,112 | $86 |
| Clobetasol Propionate | 12 | $452 | $38 |
2018: 5 drugs
| Estring | 27 | $13,153 | $487 |
| Estrace | 29 | $3,157 | $109 |
| Clobetasol Propionate | 15 | $813 | $54 |
| Estradiol | 30 | $771 | $26 |
| Triamcinolone Acetonide | 11 | $91 | $8 |
2017: 3 drugs
| Estring | 20 | $8,793 | $440 |
| Estrace | 12 | $3,702 | $309 |
| Estradiol | 27 | $955 | $35 |
2016: 4 drugs
| Clobetasol Propionate | 26 | $3,102 | $119 |
| Premarin | 12 | $2,946 | $245 |
| Estradiol | 17 | $573 | $34 |
| Medroxyprogesterone Acetate | 11 | $278 | $25 |
2015: 2 drugs
| Clobetasol Propionate | 13 | $1,418 | $109 |
| Medroxyprogesterone Acetate | 14 | $304 | $22 |
Money from drug and device companies
$22 in 2022
A payment is not proof that care is biased.
| Hologic | Fluent Fluid Management System | $22 | 1 payment
|
See the published payment
| Hologic | Meals · 2022-08-19 | Fluent Fluid Management System | $22 |
Professional record
- NPI
- 1679701767
- Licence
- CA A 108277California A108277: Current · expires 2027-01-31
- Trained
- University of Southern California Keck School of Medicine, 2007
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 710 Lawrence Expy, Women'S Clinic, Santa Clara, CA, 95051
- NPI first listed
- 2009-06-26
- NPI last updated
- 2021-12-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.